Introduction
Stroke is a major complication of sickle cell anemia (SS) in children. Its incidence is about 10% in children with SS less than 10 years of age [1] . Moreover, incidence of silent stroke detected by magnetic resonance imaging (MRI) could be as high as 35% [2] . Pathophysiologically, these strokes are most often infarctive in nature secondary to cerebrovascular occlusion. Stroke due to SS in adults is less common and is usually due to hemorrhage [1] . Risk factors for recurrent stroke in SS include acute chest syndrome, severe anemia, cerebral vasculopathy, previous stroke and transcranial Doppler ultrasound velocity > 200 cm/sec [3] . Other rare causes of recurrent stroke in patients without SS include paradoxical embolization due to patent foramen ovale [4] .
In addition, co-existent hyperviscosity or thrombophilia with patent foramen ovale increase the risk of stroke. This scenario was reported in a child with SS and patent foramen ovale [5] . In this communication we describe an adult woman with SS and stroke secondary to paradoxical embolization due to atrial septal defect.
Case Report
A 42-year-old woman with SS has been followed in our adult sickle cell program for 25 years.
Complications of her disease included acute chest syndrome, avascular necrosis of hip joints, mitral valve prolapse, migraine headaches and frequent vaso-occlusive crises (VOC). She was enrolled in the multicenter study of hydroxyurea (MSH) when she was 21 years old and has been on 2500 mg of hydroxyurea (HU) per day since then. She had an excellent response to HU with no recurrent episodes of acute chest syndrome and infrequent need for blood transfusion. After starting HU the frequency of VOC requiring hospital admissions decreased from one admission every 1 to 2 months to less than one admission per year except when HU was discontinued due to pregnancy. Her hematologic parameters before and after HU are shown in Table 1 .
At the age of 35 years she presented to the emergency room two days after developing abrupt bilateral blurry vision, left facial numbness and weakness of her left leg. Physical exam was remarkable for left lower extremity weakness which was more pronounced proximally. Vital signs were normal. All cranial nerves were intact and there was normal sensation bilaterally. She underwent exchange transfusion 2 days after admission and was started on chronic blood exchange transfusions with the assumption that she had ischemic stroke due to SS.
Follow-up transesophageal echocardiography after discharge from the hospital showed a secundum atrial septal defect with a defect size of 1.8 cm. Right heart catheterization was performed and the pulmonary flow to systemic flow (Qp/Qs) was 1.7:1 with a mean pulmonary artery pressure of 21 mm Hg. An Amplatzer atrial septal defect (ASD) closure device was deployed with transesophageal echocardiographic guidance with successful closure of the defect.
At the patient's request exchange red cell transfusions were discontinued. The patient continued treatment with HU and aspirin. Repeat MRI of the brain after repair of the atrial septal defect showed no acute infarction; there were discrete areas of encephalomalacia and gliosis in the deep white matter of the frontal lobe corresponding to the areas of infarction identified previously. To date, seven years after percutaneous repair of the atrial septal defect she has had no strokes.
Discussion
The most common cause of stroke in patients with SS is cerebral infarction in children and hemorrhage in adults. The incidence of stroke in adult patients with SS, however, is not well known and more studies are needed in this population [6] . Moreover, patients with SS are prone to other causes of stroke such as cerebral infections, hyperlipidemia, renal disease, congenital heart disease and hyperviscosity [6] . The role of HU in preventing or causing stroke is controversial. Grace et al reported resolution of cerebral artery stenosis in a child with SS treated with HU [7] . On the other hand, Sidani et al reported stroke in a patient with SS on HU and hyperviscosity due to high Hb level after HU therapy [8] . In addition, the SWITCH study was terminated early because of the increase in secondary stroke with HU [9] . Stroke due to paradoxical embolism associated with congenital heart defect has been reported in patients with SS sporadically. Dowling et al described an 11 year-old girl with recurrent bilateral, strokes associated with patent foramen ovale, antiphospholipid antibodies and increased levels of factor VIII and lipoprotein [5] . A combination of pulmonary arterial hypertension (PAH) and patent foramen ovale may cause paradoxical embolization and stroke. However, stroke has been reported in patients with patent foramen ovale in the presence or absence of PAH [10, 11] which ruling out significant pulmonary hypertension. Moreover, atrial septal defect without stroke was reported in a child with SS associated with successful closure of the defect with open heart surgery [13] .To the best of our knowledge , our patient seems to be the first patient with SS and stroke due to paradoxical embolism secondary to atrial septal defect that did not require open heart surgery for successful management. 
